IBAkteria Sp. z o.o. is a special purpose vehicle of the Institute of Biotechnology and Antibiotics which undertakes a number of scientific and R&D initiatives which are carried out with regards to:

  • insulin and insulin analogues having a modified hypoglycaemic effect,
  • recombined vaccines against human and animal pathogens, such as influenza viruses, Parvovirus, Coronavirus, the virus of classical swine fever, common liver fluke (Fasciola hepatica),
  • developing new vectors and gene expression systems in bacterial host,
  • development and delivery of isolation and purification methods (on a lab scale and on a small pilot scale) of protein and peptides obtained from production strains taking into account the necessary conditions required for transfer to commercial scale,
  • per-clinical and clinical examinations of medicinal products.

More information can be found on the web pages of the Institute of Biotechnology and Antibiotics.

Stethoscope in hand with capsule pill and molecule as medical concept